Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 24, 1992 - Issue sup83
Submit an article Journal homepage
41
Views
0
CrossRef citations to date
0
Altmetric
Miscellany

Short-Course Therapy: Improved Patient Compliance and Therapeutic Benefit: Proceedings of Symposium Held at the 5th European Congress of Clinical Microbiology and Infectious Diseases, 9–11 September, 1991, Oslo, Norway

Tom Bergan
Pages 1-45 | Published online: 02 Jan 2015

References

  • Abrahams, J. (1977). Patient compliance in therapeutic practice. Aust Fam Physician 6: 1200–1205.
  • Norrell, S. E. (1981). Accuracy of patient interviews and estimates by clinical staff in determining medication compliance. Soc Sci Med 15E: 57–61
  • Charney, E., Bynum, R., Eldredge, D., Charney, E., Bynum, R., Eldredge, D., Frank, D., MacWhinney, J. B., McNabb, N., Scheiner, A., Sumpter, E. A. and Iker, H. (1967). How well do patients take oral penicillin? A collaborative study in private practice. Pediatrics 40: 188–195.
  • Cockburn, J., Reid, A. L., Bowman, J. A. and Sanson-Fisher, R. W. (1987). Effects of intervention on antibiotic compliance in patients in general practice. Med J Aust 147: 324–328.
  • Pullar, T., Kumar, S., Tindall, H. and Feely, M. (1989). Time to stop counting the tablets? Clin Pharmacol Ther 46: 163–168
  • Weber, C. E., Sather, M. R. and Mace, D. L. (1977). Improving patient compliance through use of single daily dosages. Hosp Pharm 12: 508–510.
  • O'Hanrahan, M. and O'Malley, K. (1981). Compliance with drug treatment. Br Med J 283: 298–300.
  • Shanson, D. C. (1989). Infections of lower respiratory tract infection. In: Microbiology in Clinical Practice. Second Edition London: Wright, Butterworth & Co. Ltd. P. 288
  • Manek, N. and Wise, R. (1986). Bedside and rapid bacteriology. Br Med J 292: 573–574.
  • Dick, H. M. (1985). Monoclonal antibodies in clinical medicine. Br Med J 291: 762–764.
  • Eisenstein, B. and Engleberg, N. C. (1986). Applied molecular genetics: New tools for microbiologist and clinicians. J Infect Dis 153: 416–430.
  • Research Committee of the British Thoracic Society and Public Health Laboratory Service. Community-acquired pneumonia in adults and British hospitals in 1982–1983 (1987). A survey of aetiology, mortality, prognostic factors and outcome. Q J Med 239: 195–200.
  • Watson, I. (1982). Epidemiology and Research in General Practice. London: Royal College of General Practitioners 182: P. 175
  • Howie, J. G. R. (1976). Clinical judgement and antibiotic use in general practice. Br Med J II: 1061–1064
  • Froom, J., Culpepper, L., Grob, P., Bartelds, A., Bowers, P., Bridges-Webb, C., Grava-Gubins, I., Green, L., Lion, J., Somaini, B., Stroobant, R., West, R. and Yodfat, Y. (1990). Diagnosis and antibiotic treatment of acute otitis media: Report from the international primary care network. Br Med J 300: 582–586.
  • van Buchen, F. L., Dunk, J. H. M. and Van't Hof, M. A. (1981). Therapy of acute otitis media: Myringotomy, antibiotics or neither? A double-blind study in children. Lancet 2: 883–887.
  • Bian, D. J. G. and Haines, A. J. (1975). A year's study of drug prescribing in general practice using computer-assisted records. J R Coll Gen Pract 25: 41–48.
  • Howie, J. G. and Bigg, A. R. (1980). Family trends in psychotropic and antibiotic prescribing in general practice. Br Med J 250: 836–838.
  • Colcher, I. S. and Bass, J. W. (1972). Penicillin treatment of streptococcal pharyngitis. A comparison of schedules and the role of specific counselling. JAMA 222: 657–659.
  • Daschner, F. and Marget, W. (1975). Treatment of recurrent urinary tract infection in children. II. Compliance of parents and children with antibiotic therapy regimens. Acta Paediatr Scand 64: 105–108.
  • Glupczynski, Y., Labbé, M., Vanderlinden, M. P., Nyst, J. F. and Burette, A. (1989). Lack of antibiotic compliance in patients treated for Campylobacter pylori-associated gastritis (letter). Am J Gastroenterol 84: 1125–1126.
  • Schwartz, R. H., Rodriquez, W. J. and Grundfast, K. M. (1981). Pharmacologic compliance with antibiotic therapy for acute otitis media: Influence on subsequent middle ear effusion. Pediatrics 68: 619–622.
  • Finney, J. W., Friman, P. C., Rapoff, M. A. and Christophersen, E. R. (1985). Improving compliance with antibiotic regimens for otitis media. Randomized clinical trial in a pediatric clinic. Am J Dis Child 139: 89–95.
  • Ettlinger, P. R. A. and Freeman, G. K. (1981). General practice compliance study: Is it worth being a personal doctor? Br Med J 282: 1192–1194
  • Garrity, T. (1981). Medical compliance and the clinician patient relationship. A review. Soc Sci Med 15E: 215–222
  • Stewart, M. A. (1984). What is a successful doctor-patient interview? A study of interactions and outcomes. Soc Sci Med 19: 167–175.
  • King, N. J. and Peck, C. L. (1981). Enhancing patient compliance with medical regimens: Strategies for the general practioner. Aust Fam Physician 10: 954–959.
  • Cockburn, J., Reid, A. L. and Sanson-Fisher, R. W. (1987). The process and content of general practice consultations that involve prescription of antibiotic agents. Med J Aust 147: 321–324.
  • Leistyna, J. A. and Macaulay, J. C. (1966). Therapy of streptococcal infections. Do pediatric patients receive prescribed oral medication? Am J Dis Child 111: 22–26.
  • Lima, J., Nazarian, L., Charney, E. and Lahti, C. (1976). Compliance with short-term antimicrobial therapy: Some techniques that help. Pediatrics 57: 383–386.
  • Sharpe, T. R. and Mikeal, R. L. (1974). Patient compliance with antibiotic regimens. Am J Hosp Pharm 31: 479–484.
  • Ley, P. (1983). Giving information to patients. In: Eiser JR, ed. Social Psychology and Behavioral Medicine. New York: John Wiley
  • Eraker, S. A., Kirscht, J. P. and Becker, M. H. (1984). Understanding and improving patient compliance. Ann Intern Med 100: 258–268.
  • Cockburn, J., Gibberd, R. W. and Reid, A. L. (1987). Determinants of non-compliance with short-term antibiotic regimens. Br J Med 295: 814–818.
  • Becker, M. H., Drachman, R. H. and Kirscht, J. P. (1972). Predicting mothers' compliance with pediatric medical regimens. J Pediatr 81: 843–854.
  • Mohler, D. N., Wallin, D. G. and Dreyfus, E. G. (1955). Studies in the home treatment of streptococcal disease. I. Failure of patients to take penicillin by mouth as prescribed. N Engl J Med 252: 116–118.
  • Gordis, L., Markowitz, M. and Lilienfeld, A. M. (1969). Why patients don't follow medical advice: A study of children on long-term antistreptococcal prophylaxis. Pediatrics 75: 957–968.
  • Hurd, P. D. and Butkovich, S. L. (1986). Compliance problems and the older patient: Assessing functional limitations. Drug Intell Clin Pharm 20: 228–230.
  • Col, N., Fanale, J. E. and Kronholm, P. (1990). The role of medication non-compliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 150: 841–845.
  • Sharpe, T. R. and Mikeal, R. L. (1974). Patient compliance with antibiotic regimens. Am J Hosp Pharm 31: 479–484.
  • Greenberg, R. N. (1963). Overview of patient compliance with medication dosing: A literature review. Clin Ther 6: 592–599.
  • Bergman, A. B. and Werner, R. J. (1963). Failure of children to receive penicillin by mouth. N Engl J Med 268: 1334–1338.
  • Proceedings of a Symposium: Tissue-Directed Antibiotic Therapy (1991). Am J Med 91 ( Suppl 3A): 1S–45S

References

  • Slaney, L., Chubb, H., Ronald, A. and Brunham, R. (1990). In vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis. J Antimicrob Chemother 25 ( Suppl A): 1–5
  • Maskell, J. P., Sefton, A. M. and Williams, J. D. (1990). Comparative in vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes. J Antimicrob Chemother 25 ( Suppl A): 19–24
  • Stamm, L. V. and Parrish, E. A. (1990). In vitro activity of azithromycin and CP 63956 against Treponema pallidum. J Antimicrob Chemother 25 ( Suppl A): 11–14
  • Johnson, R. C., Kodner, C., Russell, M. and Girard, D. (1990). In vitro and in vivo susceptibility of Borrelia burgdorferi to azithromycin. J Antimicrob Chemother 25 ( Suppl A): 19–24
  • Engeset, A., Hager, B., Nesheim, A. and Kolbenstvedt, A. (1973). Studies on human peripheral lymph. I. Sampling method. Lymphol 6: 1–5.
  • Wagner, J. G. (1975). Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications. Hamilton, III
  • Foulds, G., Shepard, R. M. and Johnson, R. B. (1990). The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 25 ( Suppl A): 73–82
  • Kiruhoffer, P. (1979). Medisinsk Fysiologi. FAD's Forlag. Copenhagen. P. 886
  • Rohwedder, R., Bergan, T., Thorsteinsson, S. B. and Scholl, H. (1990). Transintestinal elimination of ciprofloxacin. Pharmacol 36: 77–84.
  • Bergan, T., Engeset, A., Olszewski, W., Josefsson, K. and Larsen, N. (1982). Penetration of erythromycin into human peripheral lymph. J Antimicrob Chemother 10: 319–324.
  • Josefsson, K., Bergan, T. and Magni, L. (1982). Dose-related pharmacokinetics after oral administration of a new formulation of erythromycin base. Br J Clin Pharmacol 13: 685–691.
  • Baldwin, D. R., Wise, R., Andrews, J. M., Ashby, J. P. and Honeybourne, D. (1990). Azithromycin concentrations at the sites of pulmonary infection. Eur Resp J 3: 886–890.

References

  • Bright, G. M., Nagel, A. A., Bordner, J., Desai, K. A., Dibrino, J. N., Nowakowska, J., Vincent, L., Watrons, R. M. and Sciavolino, F. C. (1988). Synthesis in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives; a new class of macrolide antibiotics, the azalides. J Antibiot 41: 1029–1047.
  • Retsema, J. A., Girard, A. E., Girard, D. and Milisen, W. B. (1990). Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo. J Antimicrob Chemother 25 ( Suppl A): 83–98
  • Hardy, D. W., Hensey, D. M., Beyer, J. M., Vojtko, C., McDonald, E. J. and Fernandes, P. B. (1988). Comparative in vitro activities of new 14, 15 and 15-membered macrolides. Antimicrob Agents Chemother 32: 1710–1719.
  • Maskell, J. P., Sefton, A. M. and Williams, J. D. (1990). Comparative in vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes. J Antimicrob Chemother 25 ( Suppl. A): 19–24
  • Foulds, G., Shepard, R. M. and Johnson, R. B. (1990). The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 25 ( Suppl A): 73–82
  • Foulds, G., Chan, K. H., Johnson, J. T., Shepard, R. M. and Johnson, R. B. (1991). Concentrations of azithromycin in human tonsillar tissue. Eur J Clin Microbiol Infect Dis 10: 853–856
  • Shepard, R. M. and Falkner, F. C. (1990). Pharmacokinetics of azithromycin in rats and dogs. J Antimicrob Chemother 25 ( Suppl A): 49–60
  • Casiano, R. R. (1991). Azithromycin and amoxycillin in the treatment of acute maxillary sinusitis. Amer J Med 91 ( Suppl 3A): 27S–30S
  • Hooton, T. M. (1991). A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis. Amer J Med 91 ( Suppl 3A): 23S–26S

References

  • Tager, J. and Spizer, F. E. (1975). Role of infection in chronic bronchitis. N Engl J Med 292: 563–571.
  • Anthonisen, N. R., Manfreda, J., Warren, C. P. W., Hershfield, E. S., Harding, G. K. M. and Nelson, N. A. (1987). Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106: 196–204.
  • Lode, H. (1986). Initial therapy in pneumonia: Clinical, radiographic and laboratory data important for the choice. Am J Med 80 ( Suppl A): 70–74
  • MacFarlane, J. T., Finch, R. G., Ward, M. and Macrae, A. D. (1982). Hospital study of adult community-acquired pneumonia. Lancet 2: 255–258.
  • Klimek, J. J., Ajemian, E., Fontecchio, S., Gracewski, J., Klemas, B. and Jimine, L. (1983). Community-acquired bacterial pneumonia requiring admission to hospital. Am J Infect Control 11: 79–82.
  • Woodhead, M. A., MacFarlane, J. T., McCracken, J. S., Rose, D. H. and Finch, R. G. (1987). Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1: 671–674.
  • Berntsson, E., Blomberg, J., Lagergard, T. and Trotters, B. (1988). Etiology of community-acquired pneumonia in patients requiring hospitalization. Eur J Clin Microbiol 4: 268–272.
  • Research Committee of the British Thoracic Society and the Public Health Laboratory Service (1987). Community-acquired pneumonia in adults in British Hospitals in 1982–1983. A survey of aetiology, mortality, prognostic factors and outcome. Q J Med 239: 195–220.
  • Kemmerich, B. M., Rahlwes, H., Vogel-Hartmann, K., Bartman, G., Höffken, E., Berntsson, G., Ruckdeschel, J., Wagner, H. and Lode, H. (1989). Ambulant erworbene Pneumonien. Dtsch Med Wochenschr 114: 1471–1477
  • Retsema, J., Girard, A., Shelkly, W., Manousos, M., Bright, G., Borovoy, R., Brennan, L. and Mason, R. (1987). Spectrum and mode of action of azithromycin (CP-62,993), a new 15-memberedring macrolide with improved potency against Gram-negative organisms. Antimicrob Agents Chemother 31: 1939–1947.
  • Barry, A. L., Jones, R. N. and Thornsberry, C. (1988). In vitro activity of azithromycin (CP-62, 993), clarithromycin (A-56,268; TE-031), erythromycin, roxithromycin and clindamycin. Antimicrob Agents Chemother 32: 752–754.
  • Fernandes, P. B. and Hardy, D. J. (1988). Comparative in vitro potencies of nine new macrolides. Drugs Ex Clin Res 14: 445–451.
  • Goldstein, F. W., Emirian, M. F., Controt, A. and Acar, J. F. (1990). Bacteriostatic and bactericidal activity of azithromycin against Haemophilus influenzae. J Antimicrob Chemother 25 ( Suppl A): 25–28
  • Maskell, J. P., Sefton, A. M. and Williams, J. D. (1990). Comparative in vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes. J Antimicrob Chemother 25 ( Suppl A): 19–24
  • Edelstein, P. H. and Edelstein, M. A. C. (1991). In vitro activity of azithromycin against clinical isolates of Legionella species. Antimicrob Agents Chemother 35: 180–181.
  • Ridgway, G. L., Mumtaz, G. and Fenelon, L. (1991). The in vitro activity of clarithromycin and other macrolides against the type strain of Chlamydia pneumoniae (TWAR). J Antimicrob Chemother 27 ( Suppl A): 43–45
  • Foulds, G., Shephard, R. M. and Johnson, R. D. (1990). The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 25 ( Suppl A): 73–82
  • Fiese, E. F. and Steffen, S. H. (1990). Comparison of the acid stability of azithromycin and erythromycin A. J Antimicrob Chemother 25 ( Suppl A): 39–47
  • Baldwin, D. R., Wise, R., Andrews, J. M., Ashby, J. P. and Honeyborne, D. (1990). Azithromycin concentrations at the sites of pulmonary infection. Eur Resp J 3: 886–890.
  • Fitzgeorge, R. B., Featherstone, A. S. R. and Baskerville, A. (1990). Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophila by aerosol. J Antimicrob Chemother 25 ( Suppl A): 101–108
  • Retsema, J. A., Girard, A. E., Girard, D. and Milisen, W. B. (1990). Relationship of high tissue concentrations of azithromycin to bactericidal activity in vivo. J Antimicrob Chemother 25 ( Suppl A): 83–89
  • Vallée, E., Azoulay-Dupuis, E., Bergogne-Berezin, E. and Pocidalo, J. J. (1990). Bactericidal activity of azithromycin in an experimental model of Haemophilus influenzae pulmonary infection in aged mice. Abstract no. 528. In 30th ICAAC.
  • Dark, D. (1991). Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infection. Am J Med 91 ( Suppl 3A): 315–355
  • Kinasewitz, G. (1991). Azithromycin versus cefaclor treatment for acute bacterial pneumonia. Eur J Clin Microbiol Infect Dis 10: 872–877.
  • Balmes, P., Clerc, G., Dupont, B., Labram, C., Darienta, R. and Poirier, R. (1991). Comparative study of azithromycin and amoxicillin/clavulanic acid in the treatment of lower respiratory tract infections. Eur J Clin Microbiol Infect Dis 10: 437–439.
  • Schönwald, S., Gunjaca, M., Kolacny-Babic, L., Car, V. and Gosev, M. (1990). Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias. J Antimicrob Chemother 25 ( Suppl A): 123–126
  • Schönwald, S., Sherk, V., Petricevic, J., Car, V., Majerus-Misic, L. J. and Gunjaca, M. (1991). Comparison of 3-and 5-day courses of azithromycin in the treatment of atypical pneumonias. Eur J Clin Microbiol Infect Dis 10: 877–880.

References

  • Girard, A. E., Girard, D., English, A. R., Gootz, T. D., Cimochowski, C. R., Faiella, J. A., Haskell, S. L. and Retsema, J. A. (1987). Pharmacokinetics and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob Agents Chemother 31: 1948–1954.
  • Martin, J. R., Johnson, P. and Miller, M. F. (1985). Uptake accumulation and egress of erythromycin by tissue culture cells of human origin. Antimicrob Agents Chemother 27: 314–319.
  • Tillett, W. S., McCormack, J. E. and Cambier, M. J. (1945). Treatment of lobar pneumonia with penicillin. J Clin Invest 24: 589–594.
  • Cecil, R. L., (ed.) (1948). A Textbook of Medicine. 7th ed. WB Saunders
  • Wood, B. W., Jr. (1951). A Textbook of Medicine. 8th ed. WB Saunders, p. 114.
  • Woodward, T. E., Smadeal, J. E. and Parker, R. T. (1954). Symposium on efficacy of new drugs: Therapy of typhoid fever. Med Clin North Am 38: 577–582.
  • Weinstein, L., Bachrach, L. and Perris, T. S. (1949). Studies on influence of penicillin on immune response in streptococcal pharyngitis. J Clin Invest 28: 817–820.
  • Pruul, H. and McDonald, P. J. (1992). Potentiation of the antibacterial activity of azithromycin by normal human serum. Antimicrob Agents Chemother 36: 10–16.
  • Pruul, H., Wetherall, B. L. and McDonald, P. J. (1986). In vitro killing of erythromycin-exposed group A streptococci by polymorphonuclear leukocytes. Eur J Clin Microbiol 5: 405–410.
  • Pruul, H., Wetherall, B. L. and McDonald, P. J. (1982). The susceptibility of antibiotic pretreated Gram-negative bacteria to the bactericidal activity of human neutrophil granule extract. In: Eickenberg H-U, Hahn H, Opferkuch W, eds. The Influence of Antibiotics on the Host-Parasite Relationship. Heidelberg: Springer-Verlag, 208–218
  • Van der Auwera, P., Matsumoto, T. and Husson, M. (1988). Intraphagocytic penetration of antibiotics. J Antimicrob Chemother 22: 185–192.
  • Ishiguro, M., Koga, H., Kohno, S., Hayashi, T., Yamaguchi, K. and Hirota, M. (1989). Penetration of macrolides into human polymorphonuclear leukocytes. J Antimicrob Chemother 24: 719–729.
  • Wildfeuer, A., Laufen, H., Muller-Wening, D. and Haferkamp, O. (1989). Interaction of azithromycin and human phagocytic cells. Uptake of the antibiotic and the effect on the survival of ingested bacteria in phagocytes. Arzneimittelforschung 39: 755–758.
  • Gladue R. P. and Snider M. E. (1990). Intracellular accumulation of azithromycin by cultured human fibroblasts. Antimicrob Agents Chemother 34: 1056–1060.
  • Gladue, R. P., Bright, G. M., Isaacson, R. E. and Newborg, M. F. (1989). In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells; possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 33: 277–282.

References

  • Shah, P. M., Asanger, R. and Kahan, F. M. (1991). Incidence of multi-resistance in Gram-negative aerobes from intensive care units of 10 German hospitals. Scand J Infect Dis ( Suppl 78): 22–34
  • Buirma, R. J. A., Horrevorts, A. M. and Wagenvoort, J. H. T. (1991). Incidence of multi-resistant Gram-negative isolates in eight Dutch hospitals. Scand J Infect Dis ( Suppl 78): 35–44
  • Verbist, L. (1991). Incidence of multi-resistance in Gram-negative bacterial isolates from intensive care units in Belgium: A surveillance study. Scand J Infect Dis ( Suppl 78): 45–53
  • Snydman, D. S. (1991). Clinical implications of multi-drug resistance in the intensive care unit. Scand J Infect Dis ( Suppl 78): 54–63
  • Lindberg, F. and Normark, S. (1986). Contribution of chromosomal β-lactamases to β-lactam resistance in enterobacteria. Rev Infect Dis 8 ( Suppl 3): 292–304
  • Livermore, D. M. (1991). Mechanisms of resistance to β-lactam antibiotics. Scand J Infect Dis ( Suppl 78): 7–16
  • Thomson, K. S., Weber, D. A., Sanders, C. C. and Sanders, W. E. Jr. (1990). β-Lactamase production in members of the family Enterobacteriaceae and resistance to β-lactam-enzyme inhibitor combinations. Antimicrob Agents Chemother 34: 622–627.
  • Coleman, K., Griff, R. J., Page, J. W. J. and Upshon, P. A. (1989). In vitro evaluation of BRL 42715, a novel β-lactamase inhibitor. Antimicrob Agents Chemother 33: 1580–1587.
  • Philippon, A., Labia, R. and Jacoby, G. A. (1989). Extended spectrum β-lactamases. Antimicrob Agents Chemother 33: 1131–1136.
  • Jacoby, G. A. and Carreras, I. (1989). Activities of β-lactam antibiotics against Escherichia coli strains producing extended spectrum β-lactamases. Antimicrob Agents Chemother 34: 858–862.
  • Bonati, M., Traina, G. L., Rosina, R. and Buniva, G. (1988). Pharmacokinetics of a single intravenous dose of teicoplanin in subjects with various degree of renal impairment. J Antimicrob Chemother 21 ( Suppl A): 29–37
  • Kaatz, G. W., Seo, S. M., Dorman, N. J. and Lerner, S. A. (1990). Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis. J Infect Dis 162: 103–108.
  • Widmer, A. F., Frei, R., Rajacic, Z. and Zimmerli, W. (1990). Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 162: 96–102.
  • Van der Auwera, P. (1991). Pharmacokinetic evaluation of single daily dose amikacin. J Antimicrob Chemother 27 ( Suppl C): 63–71
  • Maller, R., Ahrne, H., Eilard, T., Eriksson, I., Lausen, I. and Scandinavian Amikacin Once-Daily Study Group (1991). Efficacy and safety of amikacin in systemic infections when given as a single dose or in two divided doses. J Antimicrob Chemother 27 ( Suppl C): 63–71
  • Bergan, T. (1987). Pharmacokinetic properties of the cephalosporins. In: Williams JD, ed: The cephalosporins. Drugs 34 (Suppl 2): 89–104
  • Furet, X. Y. and Pechére, J. C. (1991). Newly documented antimicrobial activity of quinolones. Eur J Clin Microbiol Infect Dis 10: 249–254.
  • Franzblau, S. G. and White, K. E. (1990). Comparative in vitro activity of 20 fluoroquinolones against Mycobacterium leprae. Antimicrob Agents Chemother 34: 229–231.
  • Foulds, G., Shepard, R. M. and Johnson, R. B. (1990). The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 25 ( Suppl A): 73–82
  • Retsema, J. A., Girard, A. E., Girard, D. and Milisen, W. B. (1990). Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo. J Antimicrob Chemother 25 ( Suppl A): 83–89
  • Steingrimsson, O., Olafsson, J. H., Thorarinsson, H., Ryan, R. W., Johnson, R. E. and Tilton, R. C. (1990). Azithromycin in the treatment of sexually transmitted diseases. J Antimicrob Chemother 25 ( Suppl A): 100–114
  • Goldstein, F. W., Emirian, M. F., Coutrot, A. and Acar, J. F. (1990). Bacteriostatic and bactericidal activity of azithromycin against Haemophilus influenzae. J Antimicrob Chemother 25 ( Suppl A): 25–28
  • Metchock, B. (1990). In vitro activity of azithromycin compared with other macrolides and oral antibiotics against Salmonella typhi. J Antimicrob Chemother 25 ( Suppl A): 29–31

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.